IDBS Adds Synthetic Chemistry to Its Cloud-Based R&D Platform

Article

Pharmaceutical Technology's In the Lab eNewsletter

In the Lab eNewsletterPharmaceutical Technology\'s In the Lab eNewsletter-01-10-2018
Volume 13
Issue 1

The latest addition to the company’s cloud-based R&D platform provides organic chemists with the capability to transfer all experimental data to an on-premise site or cloud environment.

IDBS, a provider of advanced software for R&D organizations, has included a synthetic chemistry offering that extends its E-WorkBook Connect cloud-based platform, part of the company’s E-WorkBook Cloud, an R&D cloud platform that supports internal, external, and hybrid data management and research needs.
 
Contract research organizations (CROs) involved in medicinal chemistry and scale-up chemical intermediates face significant security, communication, and collaboration challenges with current existing tools. With the now-extended E-WorkBook Connect, organic chemists can share data externally and collaborate with partners using a secure work space. It also provides chemists with the uncommon ability to transfer all experimental data to an on-premise or hosted E-WorkBook environment.

While some CROs are allowed direct access to a secure corporate electronic laboratory notebook (ELN), others are mandated to maintain a local installation of the desktop ELN. Both approaches are an additional overhead that IDBS’ E-WorkBook Connect platform resolves, according to the company.

“Extending the capabilities of E-WorkBook Connect with stoichiometry, to support synthetic organic chemistry, addresses the data management challenges and costs associated with collaborative research, especially when it comes to communication,” said Ian Peirson, head of product planning at IDBS, in a company press release.

“The advantages are clear: with our technology, a simple email invitation process sets up a secure workspace with a collaborator, and this then enables both sides to view progress, and complete the transfer of all information and metadata to supplement the internal corporate knowledge base,” he added.

Source: IDBS

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Drug Digest: Focusing on Solid Dosage Trends and Demand
Behind the Headlines, episode 7
Related Content